Director Stephen T Zarrilli sells entire stake of 25.0K shares at $84.29, exiting GMED position amid 60.6% annual revenue growth and 26.50 P/E
Director Zarrilli liquidated his entire holding of 25,000 shares (-100.0% vs pre-transaction holdings) for $2,107,257.50 on 2025-11-11, exiting a position he held through a period of significant stock appreciation. The sale occurred at $84.29 per share, within 9.7% of the 52-week high of $93.32, while the company reports robust fundamentals: annual revenue growth of +60.6%, net income of $119.0M, and a market cap of $11.2B. The timing coincides with substantial recent momentum—the stock has risen 44.6% over 30 days and 38.7% over 90 days. The complete exit is noteworthy; insider directors often retain some stake to signal continued alignment with shareholders.